According to Vertex Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $9.86 B. In 2022 the company made a revenue of $8.93 B an increase over the years 2021 revenue that were of $7.57 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $9.86 B | 10.51% |
2022 | $8.93 B | 17.91% |
2021 | $7.57 B | 22.06% |
2020 | $6.20 B | 49.07% |
2019 | $4.16 B | 36.59% |
2018 | $3.04 B | 22.46% |
2017 | $2.48 B | 46.2% |
2016 | $1.70 B | 64.89% |
2015 | $1.03 B | 77.86% |
2014 | $0.58 B | -52.11% |
2013 | $1.21 B | -20.63% |
2012 | $1.52 B | 8.25% |
2011 | $1.41 B | 883.91% |
2010 | $0.14 B | 40.71% |
2009 | $0.10 B | -41.94% |
2008 | $0.17 B | -11.81% |
2007 | $0.19 B | -8.02% |
2006 | $0.21 B | 34.47% |
2005 | $0.16 B | 56.63% |
2004 | $0.10 B | 54.2% |
2003 | $66.61 M | -58.65% |
2002 | $0.16 B | 21.67% |
2001 | $0.13 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 842.55% | ๐บ๐ธ USA |
AbbVie ABBV | $54.31 B | 450.38% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | 174.74% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 509.11% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.00 B | 356.02% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $73.62 M | -99.25% | ๐บ๐ธ USA |